EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types

Arnaud Beddok iD, Jonas Willmann iD, Anna Embring iD, Ane L Appelt iD, Panagiotis Balermpas iD, Kevin Chua iD, J Isabelle Choi, Bernice Simone Elger iD, Dorota Gabrys iD, Peter Hoskin iD, Maximilian Niyazi iD, David Pasquier iD und 10 weitere

CA: A Cancer Journal for Clinicians · 2025

DOI: 10.3322/caac.70016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, 2025. Verfasst von Arnaud Beddok und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Institut Godinot, Reims, France. Hauptthemen laut MEDLINE: Re-Irradiation, Neoplasm Recurrence, Local, Radiotherapy, Intensity-Modulated, Radiosurgery. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reirradiation (reRT), defined as administering a course of radiation therapy to a specific area previously irradiated, is an evolving treatment strategy for locoregionally recurrent cancer that offers significant potential and poses inherent challenges. Advances in such techniques as intensity‐modulated and stereotactic body radiation therapy have improved precision, making reRT a viable option for complex scenarios previously deemed high‐risk. Nevertheless, reRT remains associated with substantial risks—including life‐threatening side effects, functional impairments, and psychosocial effects—which must be carefully balanced against the patient's overall health and the likelihood of achieving cancer control or palliation. Patient selection is essential to optimize outcomes while mitigating risks. Decisions should account for tumor characteristics at the time of primary diagnosis and recurrence, elapsed time since prior treatment, the possibility of delivering meaningful doses to the tumor, and the cumulative irradiation tolerance of normal tissues. Advanced imaging modalities, such as functional magnetic resonance imaging and fluorine‐18–labeled fluorodeoxyglucose–positron emission tomography, are important for distinguishing recurrences from treatment‐induced changes, refining treatment targets, and minimizing exposure to healthy tissue. Combined treatment with systemic regimens—targeted therapies and immunotherapy in particular—offers promising opportunities but requires coordination to manage side effects. Standardized guidelines, such as those from the European Society of Therapeutic Radiology and Oncology‐European Society for Research and Treatment of Cancer, are essential for improving the consistency of reporting, guiding clinical decision making, and fostering patient‐centered care. Multidisciplinary collaboration and ongoing research, particularly through clinical trials, are central to fully exploiting reRT strategies. In addition, the development of innovative techniques, such as proton therapy, would likely enable safer treatments. These efforts aim to improve the therapeutic balance of reRT, enhancing outcomes and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Re-IrradiationNeoplasm Recurrence, LocalRadiotherapy, Intensity-ModulatedRadiosurgeryNeoplasmsProton TherapyHumansPalliative CareMagnetic Resonance ImagingPositron-Emission TomographyPatient-Centered CareClinical Decision-MakingRadiation OncologySocieties, MedicalPractice Guidelines as TopicQuality of LifePatient SelectionPatient Care Planning

Stichwörter der Autor:innen

advanced imaging techniquesdecision‐makinglocoregional recurrenceradiation oncologyreirradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Institut Godinot, Reims, France.
  • Research Center in Information and Communication Sciences and Technologies, University of Champagne-Ardenne, Reims, France.
  • Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Arnaud Beddok, Jonas Willmann, Anna Embring, Ane L Appelt, Panagiotis Balermpas, Kevin Chua, Bernice Simone Elger, Dorota Gabrys, Peter Hoskin, Maximilian Niyazi, David Pasquier, Kelly Paradis, Orit Kaidar-Person, Nicole C Schmitt, Conor E Steuer, Juliette Thariat, Sue S Yom, Philip Poortmans, Eliana Vasquez Osorio, Nicolaus Andratschke

Zitieren

APA

Beddok, A., Willmann, J., Embring, A., Appelt, A. L., Balermpas, P., Chua, K., Choi, J. I., Elger, B. S., Gabrys, D., Hoskin, P., Niyazi, M., Pasquier, D., Paradis, K., Kaidar-Person, O., Plaisier, C., Schmitt, N. C., Steuer, C. E., Thariat, J., Yom, S. S., …, & Andratschke, N. (2025). Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.70016

Vancouver

Beddok A, Willmann J, Embring A, Appelt AL, Balermpas P, Chua K, et al. Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types. CA: A Cancer Journal for Clinicians. 2025. doi:10.3322/caac.70016

BibTeX
@article{Beddok2025,
  author = {Beddok, Arnaud and Willmann, Jonas and Embring, Anna and Appelt, Ane L and Balermpas, Panagiotis and Chua, Kevin and Choi, J Isabelle and Elger, Bernice Simone and Gabrys, Dorota and Hoskin, Peter and Niyazi, Maximilian and Pasquier, David and Paradis, Kelly and Kaidar-Person, Orit and Plaisier, Corien and Schmitt, Nicole C and Steuer, Conor E and Thariat, Juliette and Yom, Sue S and Poortmans, Philip and Vasquez Osorio, Eliana and Andratschke, Nicolaus},
  title = {Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2025},
  doi = {10.3322/caac.70016}
}
Kostenlos starten →